Tag: Mydecine - Psilocybin Alpha

New Resource: Psychedelic Legalization & Decriminalization Tracker

Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data

Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data

Post published:September 22, 2021
Post category:Press Release

Mydecine Innovations Group Announces MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical Trial

Mydecine Innovations Group Announces MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical Trial

Post published:September 7, 2021
Post category:Press Release

Mydecine Innovations Group signs five-year Master Collaboration Research Agreement with Johns Hopkins University School of Medicine

Mydecine Innovations Group signs five-year Master Collaboration Research Agreement with Johns Hopkins University School of Medicine

Post published:August 18, 2021
Post category:Press Release

Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update

Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update

Post published:August 17, 2021
Post category:Press Release

Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds

Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds

Post published:July 21, 2021
Post category:Press Release

Mydecine Innovations Group Announces Launch of Mindleap Version 2.0

Mydecine Innovations Group Announces Launch of Mindleap Version 2.0

Post published:July 13, 2021
Post category:Press Release

Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004

Mydecine Selects Substance Use Disorder and Smoking Cessation for Novel Psychedelic Molecule MYCO-004

Post published:June 24, 2021
Post category:Press Release

Mydecine Unveils Artificial Intelligence Drug Discovery Program

Mydecine Unveils Artificial Intelligence Drug Discovery Program

Post published:June 16, 2021
Post category:Press Release

Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms

Mydecine Discovers Over 40 Groundbreaking Potential Pharmacologically Active Novel Compounds in Mushrooms

Post published:June 8, 2021
Post category:Press Release

Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms

Health Canada Approves Expansion of Mydecine’s Cultivation Capabilities for Psilocybin Producing Mushrooms

Post published:May 25, 2021
Post category:Press Release

End of content

No more pages to load

Psilocybin Alpha

The definitive resource for investors in the emergent psychedelic medicine sector. Cut through the shroom stock noise with exclusive news, interviews, data and private financing opportunities.

Quick Links

Newsletter

Industry insights and interviews delivered to your inbox. No spam, just valuable information.